Swansea University: Major International Clinical Trial Finds Significant Impact of Semaglutide on People With Type 2 Diabetes
June 13, 2025
June 13, 2025
SWANSEA, Wales, June 13 -- Swansea University issued the following news:
* * *
Major international clinical trial finds significant impact of semaglutide on people with type 2 diabetes
An international clinical trial, led in the UK by Swansea's Joint Clinical Research Facility (JCRF), has found that semaglutide tablets - best known as the active ingredient in some weight-loss treatments - can 'significantly' help reduce the risk of heart atta . . .
* * *
Major international clinical trial finds significant impact of semaglutide on people with type 2 diabetes
An international clinical trial, led in the UK by Swansea's Joint Clinical Research Facility (JCRF), has found that semaglutide tablets - best known as the active ingredient in some weight-loss treatments - can 'significantly' help reduce the risk of heart atta . . .